Medigen Vaccine Biologics Corp. engages in the research, development, and wholesale of vaccine and biopharmaceutical, and wholesale and retail of medical devices. The company was founded on October 12, 2012 and is headquartered in Zhubei, Taiwan.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange MEDIGEN VACCINE BIOLOGICS CORPORATE stocks are traded under the ticker 6547.
MEDIGEN VACCINE BIOLOGICS CORPORATE is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
Like other stocks, 6547 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIGEN VACCINE BIOLOGICS CORPORATE stock right from TradingView charts — choose your broker and connect to your account.
6547 reached its all-time high on May 17, 2021 with the price of 280.2 TWD, and its all-time low was 15.1 TWD and was reached on Aug 24, 2015. See other stocks reaching their highest and lowest prices.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDIGEN VACCINE BIOLOGICS CORPORATE EBITDA is −1.08 B TWD, and current EBITDA margin is −277.87%. See more stats in MEDIGEN VACCINE BIOLOGICS CORPORATE financial statements.